Literature DB >> 21466364

Age-dependent reference ranges for automated assessment of immature granulocytes and clinical significance in an outpatient setting.

Michael H A Roehrl1, Donald Lantz, Crystal Sylvester, Julia Y Wang.   

Abstract

CONTEXT: New generations of hematology analyzers have made the routine automated quantification of immature granulocytes (IGs) in peripheral blood samples accessible as a powerful clinical parameter.
OBJECTIVE: The use of IGs has previously been studied mostly in hospitalized patients with sepsis. We investigated the use of IGs in the outpatient setting. Establishment of precise normal outpatient IG reference ranges is a prerequisite for clinically meaningful interpretation of the parameter.
DESIGN: We analyzed a large outpatient population comprising more than 2400 samples to determine age-stratified normal reference ranges for IGs.
RESULTS: Using nonparametric statistical approaches, we show that 1-tailed 95th percentile estimates for relative and absolute IG concentrations up to the age of 10 years are 0.30% and 30.0 µL(-1), respectively. For individuals above the age of 10 years, the respective 95th percentile estimates are approximately twice as large at 0.74% and 60.0 µL(-1). No differences were seen between male and female reference ranges. Taking nonparametric 90% confidence intervals for each estimate into account, we recommend the following IG upper reference range limits for routine outpatient use: 0.30%/40.0 µL(-1) (≤10 years) and 0.90%/70.0 µL(-1) (>10 years). Up to the age of 10 years, the most common pathologies associated with elevated IG counts in outpatients were infections, in particular, otitis media, upper and lower respiratory infections, and gastroenteritis. By contrast, above the age of 10 years, the most common causes were hematologic malignancies, drug therapy (glucocorticoids, chemotherapy), severe infections, and pregnancy (young females).
CONCLUSIONS: The use of appropriate reference ranges makes IGs a powerful hematologic parameter for outpatient care that is associated with differential diagnoses that are distinctly characteristic of that setting.

Entities:  

Mesh:

Year:  2011        PMID: 21466364     DOI: 10.5858/2010-0258-OA.1

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  7 in total

1.  Predictors of COVID-19 Hospital Treatment Outcome.

Authors:  Ryszard Tomasiuk; Jan Dabrowski; Jolanta Smykiewicz; Magdalena Wiacek
Journal:  Int J Gen Med       Date:  2021-12-22

2.  Evaluation of Immature Granulocyte Count as the Earliest Biomarker for Sepsis.

Authors:  Prabhav Bhansaly; Sudhir Mehta; Nidhi Sharma; Esha Gupta; Shaurya Mehta; Sweta Gupta
Journal:  Indian J Crit Care Med       Date:  2022-02

3.  Identification of immature granulocytes in cancer chemotherapy patients by cell counting vs. microscopic examination of blood smears.

Authors:  Yi-Qun Che; DI Shen; Shi-Min Zhang; Jun Qi
Journal:  Mol Clin Oncol       Date:  2014-01-14

4.  Automated measurement of immature granulocytes: performance characteristics and utility in routine clinical practice.

Authors:  Balamurugan Senthilnayagam; Treshul Kumar; Jayapriya Sukumaran; Jeya M; Ramesh Rao K
Journal:  Patholog Res Int       Date:  2012-02-15

5.  Leukocyte populations and C-reactive protein as predictors of bacterial infections in febrile outpatient children.

Authors:  Zühre Kaya; Aynur Küçükcongar; Doğuş Vurallı; Hamdi Cihan Emeksiz; Türkiz Gürsel
Journal:  Turk J Haematol       Date:  2014-03-05       Impact factor: 1.831

6.  Trans-cortical vessels in the mouse temporal bulla bone are a means to recruit myeloid cells in chronic otitis media and limit peripheral leukogram changes.

Authors:  Ali Azar; Mahmood F Bhutta; Jorge Del-Pozo; Elspeth Milne; Michael Cheeseman
Journal:  Front Genet       Date:  2022-09-28       Impact factor: 4.772

7.  Assessment of Immature Granulocytes Percentage to Predict Severe Bacterial Infection in Latvian Children: An Analysis of Secondary Data.

Authors:  Jana Pavare; Ilze Grope; Dace Gardovska
Journal:  Medicina (Kaunas)       Date:  2018-08-10       Impact factor: 2.430

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.